Together with their well-known regulatory functions on lymphocytes extensively reviewed elsewhere (6, 7, 22, 23, 35), circulating and tumor-infiltrating myeloid cells can express PD-L1, PD-1 and Fcγ receptors (FcγR) and can thus directly bind to ICIs and modulate their activity. This evidence concerns the gene PDCD1 and neoplasm.